Akari Therapeutics grants director Bazemore restricted stock units for unpaid cash retainers
AKTX•Akari Therapeutics granted director Robert B. Bazemore restricted stock units in lieu of unpaid cash retainers. The brief also says he received options covering 60,000 American Depositary Shares and grants of 13,100 and 4,677 shares.
1. Director awards
Akari Therapeutics granted director Robert B. Bazemore stock options covering 60,000 American Depositary Shares on August 18, 2026. The options comprise awards covering 45,000 and 15,000 shares, both expiring August 18, 2036. Bazemore also received grants of 13,100 American Depositary Shares on August 18 and 4,677 on October 5, 2026.
